News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Pfizer Inc. Teams With India Brewmaster in Return to $14 Billion Insulin Market
February 24, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Biocon Ltd. founder Kiran Mazumdar- Shaw learned the intricacies of enzymes while studying how to make beer. Now Pfizer Inc., the world’s largest drugmaker, is tapping that knowledge to revive its insulin business.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
Pfizer
MORE ON THIS TOPIC
Immunology and inflammation
Neurocrine Goes to China To Grow Pipeline in up to $881M TransThera Deal
November 3, 2025
·
1 min read
·
Dan Samorodnitsky
Layoff Tracker
Sensei Plans to Cut Workforce While Considering Strategic Alternatives
November 3, 2025
·
77 min read
·
BioSpace Editorial Staff
Mergers & acquisitions
UPDATE: Pfizer Files Lawsuits Against Novo Nordisk, Metsera To Stop Rival Bid
November 3, 2025
·
4 min read
·
Tristan Manalac
Editorial
Novo’s CEO Doesn’t Seem To Mind Being Big Pharma’s Villian
October 31, 2025
·
3 min read
·
Annalee Armstrong
